The increase in price target by a reputable analyst like Peter Grom from UBS is a strong signal to the market, often leading to increased investor confidence and a potential short-term rise in the stock price. As the rating is maintained at Buy and the target is raised, it suggests that UBS has a positive outlook on Procter & Gamble's financial health and market position.